Marshall Wace’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Sell
33,752
-117,038
-78% -$3.81M ﹤0.01% 2086
2025
Q4
$4.94M Sell
150,790
-36,518
-19% -$898K ﹤0.01% 1166
2025
Q3
$3.34M Sell
187,308
-454,126
-71% -$6.59M ﹤0.01% 1371
2025
Q2
$6.96M Sell
641,434
-26,821
-4% -$351K 0.01% 987
2025
Q1
$12.4M Buy
668,255
+576,664
+630% +$10.4M 0.02% 690
2024
Q4
$1.51M Sell
91,591
-18,763
-17% -$266K ﹤0.01% 1555
2024
Q3
$1.55M Buy
+110,354
New +$1.22M ﹤0.01% 1466
2022
Q2
Sell
-60,923
Closed -$484K 3409
2022
Q1
$484K Sell
60,923
-129,019
-68% -$1.11M ﹤0.01% 2790
2021
Q4
$1.78M Buy
+189,942
New +$2.28M ﹤0.01% 2113
2020
Q3
Sell
-87,351
Closed -$807K 1568
2020
Q2
$807K Buy
+87,351
New +$783K 0.01% 1064
2019
Q4
Sell
-79,211
Closed -$989K 1686
2019
Q3
$989K Sell
79,211
-76,359
-49% -$1.26M 0.01% 949
2019
Q2
$3.08M Sell
155,570
-72,122
-32% -$1.54M 0.03% 638
2019
Q1
$4.79M Sell
227,692
-1,217,773
-84% -$22.2M 0.05% 483
2018
Q4
$29.5M Buy
1,445,465
+364,923
+34% +$11.4M 0.3% 61
2018
Q3
$39.8M Sell
1,080,542
-88,411
-8% -$3.86M 0.34% 71
2018
Q2
$58.7M Buy
+1,168,953
New +$51.5M 0.88% 20

Other funds holding AXGN

Marshall Wace's AXGN Position: Q1 2026 in Review

Marshall Wace reduced its Axogen (AXGN) stake by 78% in Q1 2026, selling an estimated $3.81M and leaving 33,752 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

Marshall Wace first reported a position in AXGN in Q2 2018 and has held it in 16 quarters since. The position peaked at $58.7M in Q2 2018. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Marshall Wace held 33,752 shares of Axogen worth $1.12M as of Q1 2026.
  • Marshall Wace sold 117,038 Axogen shares in Q1 2026, an estimated $3.81M.
  • Axogen made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2086 holding.
  • Marshall Wace first reported a position in Axogen in Q2 2018 and has held it in 16 quarters since.
  • Marshall Wace's Axogen position peaked at $58.7M in Q2 2018.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.